December 5, 2016

AbbVie and Johns Hopkins to Collaborate on Cancer Research

Share to Facebook Share to Twitter Share to Linkedin Email Sign Up for Alerts Print

NORTH CHICAGO, Ill. and BALTIMORE, Dec. 5, 2016 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, and the Johns Hopkins University School of Medicine today announced that they signed a five-year collaboration agreement with the goal of advancing medical oncology research and discovery at both organizations.

Designed to build strong collaboration between AbbVie and Johns Hopkins Medicine researchers, the agreement will focus on several areas of oncology research, which could include lung, colorectal, breast, prostate and hematological cancer.

"As an alumnus and a former faculty member of the Johns Hopkins University School of Medicine, I know from my own experience that we will be able to combine AbbVie's expertise in oncology with some of the most talented academic researchers in the field of medicine today," said Gary Gordon, M.D., Ph.D., vice president, oncology clinical development, AbbVie. "This collaboration will combine our resources and talent with Johns Hopkins Medicine to help further advance our ability to develop new therapies available for cancer patients in need."

The agreement allows Johns Hopkins Medicine physicians and scientists access to explore new therapies developed by AbbVie for use in preclinical research funded by the collaboration. In addition, the relationship includes opportunities for research and development teams from both organizations to work closely to promote scientific knowledge exchange. AbbVie also gains an option for an exclusive license to certain Johns Hopkins Medicine discoveries made under the agreement.

"The importance of cancer research is critical to developing new therapies that could have life-changing implications," said William Nelson, M.D., Ph.D., Director, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. "Opportunities to advance science and further research help move us in a direction to yield positive outcomes."

As part of the collaborative agreement, a joint steering committee consisting of representatives from each organization will determine the research projects that the collaboration will undertake. Researchers from Johns Hopkins and AbbVie will also participate in an annual symposium to discuss their joint research and evaluate potential new projects.

About AbbVie  
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.

About Johns Hopkins Medicine
Johns Hopkins Medicine (JHM), headquartered in Baltimore, Maryland, is an $8 billion integrated global health enterprise and one of the leading academic health care systems in the United States. JHM unites physicians and scientists of the Johns Hopkins University School of Medicine with the organizations, health professionals and facilities of The Johns Hopkins Hospital and Health System. JHM's vision, "Together, we will deliver the promise of medicine," is supported by its mission to improve the health of the community and the world by setting the standard of excellence in medical education, research and clinical care. Diverse and inclusive, JHM educates medical students, scientists, health care professionals and the public; conducts biomedical research; and provides patient-centered medicine to prevent, diagnose and treat human illness. JHM operates six academic and community hospitals, four suburban health care and surgery centers, and 40 primary and specialty care outpatient sites under the umbrella of Johns Hopkins Community Physicians. JHM extends health care into the community and globally through Johns Hopkins Home Care Group, Johns Hopkins Medicine International and Johns Hopkins HealthCare. The Johns Hopkins Hospital, opened in 1889, has been ranked #1 in the nation by U.S. News & World Report for 22 years of the survey's 27-year history. For more information about Johns Hopkins Medicine; its research, education and clinical programs; and for the latest health, science and research news, visit www.hopkinsmedicine.org.
 

AbbVie logo

 


Contact

Bret Coons
+1 (847) 937-0314
bret.coons@abbvie.com

 

SOURCE AbbVie